November 17, 2022
FDA: Class I recall of Insulet Omnipod DASH PDM
Editor's Note
The Food and Drug Administration (FDA) on November 16 identified the recall by Insulet of its Omnipod DASH Insulin Management System Personal Diabetes Manager (PDM) as Class I, the most serious.
The recall was initiated because of PDM battery issues, including:
- Battery swelling
- Fluid leakage from the battery
- Extreme overheating that may pose a fire hazard.
The company reports 455 complaints, three fires, and no injuries or deaths.
Distribution dates were July 27, 2018, to August 31, 2022.
Free Daily News
- Leadership session: Empowering Your Team to Ensure Patient Safety
- ASC luncheon: Quality Measure Reporting Updates for ASCs
- Leadership session: Establishing an Environment of Continuous Improvement
- Business session: Profitability in the OR—Benchmark Your OR's Performance
- Leadership session: Managing Disruptive Behavior—A New Approach to Better Communication
- Leadership session: Activating Tomorrow's Leaders...Today!
- Leadership workshop: Effectively Coping with Stress–The Case for Wellness Integration
- Pre-conference: Offsite Facility Tours—Experiential Education
- Opening keynote: Passionate Leadership—Soaring to New Heights
- New leader workshop: Key Budgeting Components for Success
- Vascular Surgeon Opportunity at Tertiary Care and Level II Trauma Center in Beautiful New England - Northern Light Eastern Maine Medical Center - Bangor, ME
- RN- Surgery (FT) $10,000 Hiring Incentives! - Spencer Hospital - Spencer, IA
- RN- Behavioral Health Services (FT) $10,000 Hiring Incentive! - Spencer Hospital - Spencer, IA
- RN- Inpatient Services (FT) $15,000 Hiring Incentive! - Spencer Hospital - Spencer, IA
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity